CO-SpOnSOrEd By Promedica International and Cedars-Sinai Medical Center in cooperation with the California

Chapter of the American College of Cardiology, the British Cardiovascular Society, the California Society of Thoracic

Surgeons, the American College of Cardiology Foundation, the American Heart Association, and under the auspices

of the International Academy of Cardiology

22nd Annual Meeting of the California ACC

prOgram dirECTOrS: Gregory P. Fontana, MD, FACC,

Raj Makkar, MD, FACC, P.K. Shah, MD, FACC, Alfredo Trento, MD,

John G. Harold, MD, MACC & George L. Smith, MD, FACC

WH

AT

TH

EY

’RE

SA

YIN

G:

: : c

onsi

sten

tly g

reat

con

fere

nce

, yea

r aft

er y

ear!

: : A

s al

way

s, th

e “c

ontr

over

sies

” com

mitt

ee p

rese

nte

d

the

late

st a

nd

gre

ates

t in

car

dio

vasc

ula

r res

earc

h a

nd

tr

eatm

ent i

n a

pro

voca

tive

and

inn

ovat

ive

form

at.

: : A

wel

l-des

erve

d re

puta

tion

for a

hig

h-q

ual

ity p

rogr

am!

: : Fo

rmat

was

exc

elle

nt f

or h

eari

ng

con

flic

tin

g vi

ews

of

exp

erts

on

topi

cs re

leva

nt t

o m

y c

linic

al p

ract

ice.

: : t

he

pres

enta

tion

s w

ere

info

rmat

ive

and

en

tert

ain

ing.

O

ne

of th

e be

st m

eeti

ngs

I’ve

att

end

ed!

: : e

xcel

len

t cou

rse,

I le

arn

ed a

lot f

rom

the

deb

ate

form

at.

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

The Eleventh in the Series • October 13 & 14, 2011The Beverly Hills Hotel – Beverly Hills, California

EndOrSEd By The Society of Thoracic Surgeons

: : Aortic Stenting: : Aortic Surgery: : Arrhythmias: : Atherosclerosis: : Anti-thrombotic Therapy: : Carotid Stenting and

Surgery: : Cell Therapy

: : Congenital Heart Disease in Adults

: : Congestive Heart Failure: : Coronary Surgery: : Drug Eluting Stents: : Healthcare Policy: : Imaging: : Minimally Invasive Surgery

: : New Devices: Cardiac Resynchronization, Heart Failure Monitors

: : Percutaneous Valve Repair and Replacement

: : Stem Cell Therapy: : Valvular Heart Disease: : Other

PRO G R A M DE S C R I P T ION

We are proud to be celebrating the eleventh annual Controversies and Advances in the Treatment of Cardiovascular Disease symposium this year! The two-day scientific program will offer realistic views on many controversial issues involved in the diagnosis and treatment of coronary artery disease, congestive heart failure, atrial fibrillation, structural heart disease – aortic and mitral, and hypertension. New sessions for this year include imaging and electrophysiology.

The scientific program will consist of sessions focused on treatment options for specific cardiovascular disease states. Each session will include a combination of case presentations, cross-fires, discussion panels, and question and answer periods. A faculty of internationally known leaders in the field has been invited to share their knowledge and experiences with complex and controversial cases.

TA RG E T Au DI E NC E

The conference is designed for cardiologists, cardiovascular and thoracic surgeons, interventional cardiologists, perfusionists, ICU nurses, technicians and those involved in the diagnosis, treatment and care of individuals with controversial and complex cases of cardiac disease.

L E A R N I NG OBJ E C T I V E S

Upon completion of this course, participants should be able to:

C A L L FOR A B ST R AC TS

Submissions of original abstracts are being accepted and will be considered for oral presentation and poster display when submitted online at www.promedicacme.com. The International Abstract Competition will be held Wednesday, October 12, 2011 from 6:00 – 8:00 PM.

Deadline for Abstract Submissions: September 23, 2011

Abstract Categories

: : Measure the benefits and limitations of the available treatments for congestive heart failure, including new drug therapies, transplant, assist devices, percutaneous left ventricular reconstruction, cell therapy, and palliative care.

: : Compare and contrast mitral valve therapies, including edge-to-edge repair and a minimally invasive surgical approach, and discuss the future direction of treatment options.

: : Understand the recent trials, points of contention, association viewpoints, lessons learned from carotid stenting, and the future direction for transcatheter aortic valve replacement.

: : Evaluate different imaging modalities and their roles in coronary artery disease, heart failure, and aortic valve replacement.

: : Compare and contrast coronary artery disease treatments – medical, PCI, and surgery.

: : Understand the controversies in the treatment of hypertension in the elderly.

: : Learn about electrophysiological and hybrid approaches to treating atrial fibrillation.

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

The Eleventh in the Series • October 13 & 14, 2011

K EY NOT E SPE A K E R S

Nicholas A. Boon, MD, FACCWith expertise in the management of coronary heart disease, heart muscle disease, and valvular heart disease, Dr. Boon is the esteemed President of the British Cardiovascular Society, a Consultant Cardiologist at the Edinburgh Royal Infirmary, and Honorary Reader at Edinburgh University. He has contributed extensively to the field of cardiovascular research with well over 100 journal articles and has been instrumental in the ongoing investigation of the connection between air pollution and cardiovascular diseases.

William E. Cohn, MDAlong with his many academic appointments, Dr. Cohn is the Director of Minimally Invasive Surgical Technology at the Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas. Dr. Cohn has published extensively in peer reviewed journals, has authored many textbook chapters, and serves on the editorial board of the Heart Surgery Forum, Innovations, and CTS Net. He has more than 40 patents awarded or pending for his medical device innovations and has been honored as the Distinguished Inventor of the Year by the Intellectual Property Owners Association.

James L. Cox, MDDr. Cox is best recognized for his work in cardiac arrhythmia surgery and in the development of the Cox-Maze Procedure for the treatment of atrial fibrillation. He has trained many prominent surgeons in America, Europe, and Asia and has been the recipient of many prestigious awards. Dr. Cox is the Emeritus Evarts A. Graham Professor of Surgery at Washington University School of Medicine in St. Louis as well as the President and CEO of The World Heart Foundation.

David R. Holmes, Jr., MD, FACCDue to his many contributions to the field of cardiology, Dr. Holmes is the current esteemed President of the American College of Cardiology. Over the years, Dr. Holmes has been recognized with numerous awards, including the ACC Distinguished Scientist Award (Clinical Domain), has published extensively and serves on the editorial boards of many journals. He is the Edward W. and Betty Knight Scripps Professor in Cardiovascular Medicine at the Mayo Clinic College of Medicine in Rochester, Minnesota.

Michael J. Mack, MD, FACCLong recognized as a thought-leader in the fields of percutaneous valve therapy and minimally invasive cardiothoracic surgery, Dr. Mack is the current esteemed President of the Society of Thoracic Surgeons. He also serves as Medical Director of Cardiovascular Surgery for the Baylor Healthcare System, is Chairman of the Heart Hospital, Baylor Plano Research Center and is Chairman of the Cardiopulmonary Research Science & Technology Institute (CRSTI).

Albert Starr, MD, FACCA recipient of many honors, including the prestigious Lasker Award, Dr. Starr is well known as the co-inventor of the world’s first artificial valve, the Starr-Edwards Heart Valve and as the only US surgeon to assist in the first computer-assisted open heart surgery at Paris' Broussais Hospital. In addition to his pioneering works, Dr. Starr has taught more than 250 heart specialists through the St. Vincent’s Fellows Program, who are now performing surgery all over the world.

Julie A. Swain, MDFrom her vantage point within the US Food and Drug Administration, Dr. Swain is in a unique position to enlighten attendees with her keynote lecture, “Where is the FDA Heading with New Device Approval?”. A highly respected cardiothoracic surgeon, Dr. Swain was notably elected to the AATS as the fourth female member in 1991. Her recent work with the FDA’s Division of Cardiovascular Devices has preserved her legacy within the surgical community.

Program Directors

Gregory P. Fontana, MD, FACCCedars-Sinai Heart InstituteLos Angeles, CA

Raj Makkar, MD, FACCCedars-Sinai Heart InstituteLos Angeles, CA

P.K. Shah, MD, FACCCedars-Sinai Heart InstituteLos Angeles, CA

Alfredo Trento, MDCedars-Sinai Heart InstituteLos Angeles, CA

John G. Harold, MD, MACCCedars-Sinai Heart InstituteLos Angeles, CA

George L. Smith, MD, FACCNorthern California Medical AssociatesSanta Rosa, CA

Local Faculty

Daniel S. Berman, MD, FACC

Bojan Cercek, MD, PhD, FACC

Wen Cheng, MD

Kuang-Yuh Chyu, MD

Lawrence S.C. Czer, MD, FACC

Suhail Y. Dohad, MD, FACC

Fardad Esmailian, MD

Bruce L. Gewertz, MD

Swaminatha Gurudevan, MD, FACC

Saibal Kar, MD, FACC

Ronald P. Karlsberg, MD, FACC

Robert M. Kass, MD

Sanjay Kaul, MD, FACC

Ali Khoynezhad, MD, PhD, FACC

Asher Kimchi, MD, FACC

Michelle Kittleson, MD, PhD, FACC

Norman E. Lepor, MD, FACC

Frank Litvack, MD, FACC

Eduardo Marbán, MD, PhD, FACC

James K. Min, MD, FACC

Jaime D. Moriguchi, MD, FACC

Jignesh Patel, MD, PhD, FACC

Danny Ramzy, MD, PhD

Bruce A. Samuels, MD, FACC

Ernst Schwarz, MD, PhD, FACC

Takahiro Shiota, MD, FACC

Robert J. Siegel, MD, FACC

Charles D. Swerdlow, MD, FACC

Kirsten Tolstrup, MD,FACC

Ronald G. Victor, MD, FACC

Guest Faculty

Niv Ad, MDInova Heart and Vascular InstituteFalls Church, VA

Joseph E. Bavaria, MDUniversity of Pennsylvania Medical CenterPhiladelphia, PA

Nicholas A. Boon, MD, FACCUniversity of EdinburghEdinburgh, United Kingdom

David L. Brown, MD, FACCThe Heart Hospital Baylor PlanoDallas, TX

Michael Buch, MDUCLA David Geffen School of MedicineLos Angeles, CA

Matthew J. Budoff, MD, FACCUCLADavid Geffen School of MedicineLos Angeles, CA

Anson Cheung, MDSt. Paul's HospitalVancouver, Canada

W. Randolph Chitwood, Jr., MD, FACCEast Carolina University Brody School of MedicineGreenville, NC

David J. Cohen, MD, FACCSaint Luke's Mid America Heart InstituteKansas City, MO

William E. Cohn, MDTexas Heart InstituteHouston, TX

Martin R. Cowie, MDImperial College LondonLondon, United Kingdom

Faculty

James L. Cox, MDWashington University School of MedicineSt. Louis, MO

George D. Dangas, MD, PhD, FACCThe Mount Sinai Medical CenterNew York, NY

Ted Feldman, MD, FACCEvanston HospitalEvanston, IL

Borut Gersak, MDUniversity Medical Center LjubljanaLjubljana, Slovenia

Huon H. Gray, MD, FACCSouthampton University HospitalSouthampton, United Kingdom

Rory Hachamovitch, MD, MSc, FACCCleveland ClinicCleveland, OH

David R. Holmes, Jr., MD, FACCMayo ClinicRochester, MN

Dipti Itchhaporia, MD, FACCHoag Heart & Vascular Institute Newport Beach, CA

Samir Kapadia, MD, FACCCleveland ClinicCleveland, OH

Norman Kaplan, MDUT Southwestern Medical CenterDallas, TX

Morton J. Kern, MD, FACCUniversity of California, IrvineSchool of MedicineIrvine, CA

Susheel K. Kodali, MDColumbia University Medical CenterNew York, NY

Jonathan A. Leipsic, MDSt. Paul’s HospitalVancouver, Canada

Michael J. Mack, MD, FACCHeart Hospital Baylor PlanoPlano, TX

Giuseppe Mancia, MD, PhDUniversity Milano-BicoccaMonza, Italy

Jeffrey C. Milliken, MDUC Irvine Medical CenterOrange, CA

Jeffrey W. Moses, MD, FACCColumbia University Medical CenterNew York, NY

Matthew J. Price, MD, FACCScripps Clinic Scripps Translational Science InstituteLa Jolla, CA

Subha Raman, MD, FACCThe Ohio State UniversityColumbus, OH

Rita F. Redberg, MD, FACCUniversity of California San Francisco Medical CenterSan Francisco, CA

Josep Rodés-Cabau, MDQuébec Heart & Lung InstituteQuébec City, Canada

Gary Roubin, MD, PhD, FACCLenox Hill HospitalNew York, NY

Carlos E. Ruiz, MD, PhD, FACCLenox Hill HospitalNew York, NY

Joseph F. Sabik III, MD, FACCThe Cleveland Clinic FoundationCleveland, OH

Samin K. Sharma, MD, FACCThe Mount Sinai Medical CenterNew York, NY

Leslee J. Shaw, PhD, FACCEmory University School of MedicineAtlanta, GA

Charles A. Simonton, MD, FACCAbbott Vascular Santa Clara, CA

Albert Starr, MD, FACCOregon Health and Science UniversityProvidence Health and ServicesPortland, OR

Julie A. Swain, MDFood and Drug Administration Washington, DC

Valavanur A. Subramanian, MD, FACCLenox Hill HospitalNew York, NY

Rakesh Mark Suri, MD, DphilMayo ClinicRochester, MN

David Taggart, MD, PhDUniversity of OxfordHeadington, United Kingdom

Vinod H. Thourani, MD, FACCEmory University School of MedicineAtlanta, GA

Thomas J. Wang, MD, FACCMassachusetts General HospitalBoston, MA

Mathew R. Williams, MD, FACCColumbia University College of Physicians and SurgeonsNew York, NY

Preliminary Scientific Program

OctOber 12, 2011, 6:00 – 8:00 PM

International Abstract competition and Welcome reception

October 13-14, 2011

Keynote Lectures

Restoring Normal Sinus Rhythm James L. Cox, MD

A Cherry Blossom Moment in the History of Heart Disease Albert Starr, MD, FACC

Transcatheter Valve Therapy: A Professional Perspective from ACC and STS David R. Holmes, Jr., MD, FACC, and Michael J. Mack, MD, FACC

Calcific Aortic Stenosis: Getting Blood from a StoneNicholas A. Boon, MD, FACC

Way Outside the BoxWilliam E. Cohn, MD

Where is the FDA Heading with New Device Approval?Julie A. Swain, MD

Imaging

Role of Coronary CT Angiography in Stable Suspected Coronary Artery DiseaseJames K. Min, MD, FACC

Role of Cardiac Magnetic Resonance in Heart FailureSubha Raman, MD, FACC

DebAte: ct is More Accurate than echo for Aortic Annular Assessment in Patients Undergoing transcatheter Aortic Valve replacement: : Jonathan A. Leipsic, MD, FACC: : Robert Siegel, MD, FACC

DebAte: coronary Artery calcium Scoring is Superior to crP for Stratification of Intermediate-risk Asymptomatic Patients: : Leslee J. Shaw, PhD, FACC: : Thomas J. Wang, MD, FACC

DebAte: Anatomy vs Ischemia for Selection of Patients for Invasive coronary Angiography: : Matthew J. Budoff, MD, FACC: : Rory Hachamovitch, MD, MSC, FACC

coronary Heart Disease

crOSS FIre: Stable Multivessel cAD: Initial treatment : : Medical Therapy Sanjay Kaul, MD, FACC

: : PCI David J. Cohen, MD, FACC

: : Surgery David Taggart, MD, PhD

DebAte: PcI Appropriateness Guidelines: : Overused with No Patient Benefit Ted Feldman, MD, FACC

: : Are Critical to Regulate the Trade and Improve Patient Outcomes?

Rita F. Redberg, MD, FACC

DebAte: bioabsorbable Stents: the Future: : Pro Charles A. Simonton, MD, FACC

: : Con George D. Dangas, MD, PhD, FACC

DebAte: FFr Should be required for All Lesions in Stable cAD being considered for PcI: : Pro Morton J. Kern, MD, FACC

: : Con Jeffrey W. Moses, MD, FACC

Preventing Atherosclerosis: Have We Made any Progress?P.K. Shah, MD, FACC

Industry Panel

DebAte: Dual Antiplatlet therapy After DeS: : Should be Continued After One Year Samin K. Sharma, MD, FACC

: : No Evidence After One Year George D. Dangas, MD, PhD, FACC

DebAte: Left Main Disease: : PCI is Appropriate in Most Cases Raj Makkar, MD, FACC

: : PCI Should be Reserved for Inoperable Patients or Straightforward Ostial Disease

David Taggart, MD, PhD

: : We Need a Trial to Determine Best Therapy Joseph F. Sabik, III, MD, FACC

congestive Heart Failure (cHF) treatment Options for an Aging cHF Population

treAtMent OPtIOnS FOr An AGInG cHF POPULAtIOn

New Drug TherapiesMartin R. Cowie, MD

Heart TransplantationMichelle Kittleson, MD, PhD, FACC

Small Format Assist DevicesAnson Cheung, MD

Percutaneous Left Ventricular Reconstruction

Cell TherapyEduardo Marbán, MD, PhD, FACC

Palliative CareErnst Schwartz, MD, PhD, FACC

Crossfire

electrophysiology

DebAte: Atrial Fibrillation: : Transcatheter Approaches Require

No Additional Access Michael H. Buch, MD

: : Totally Endoscopic Transabdominal Subxyphoid Hybrid Ablation for Persistent Atrial Fibrillation

Borut Gersak, MD

: : Hybrid Strategies are the Best Option for Cure Niv Ad, MD

: : Rate Control and Left Atrial Occlusion is Sufficient Treatment

Saibal Kar, MD, FACC

Crossfire

Structural Heart Disease: Aortic Valve transcatheter Aortic Valve replacement

tHe trIALS

International SAPIEN ResultsJosep Rodés-Cabau, MD

International CoreValve Results

PARTNER IB (Inoperable)Susheel K. Kodali, MD

PARTNER IA (High-risk Operable)Samir Kapadia, MD, FACC

POIntS OF cOntentIOn

StrokeSusheel K. Kodali, MD

Utility vs. FutilityDavid R. Holmes, Jr., MD, FACC and Michael J. Mack, MD, FACC

Who Should be Performing TAVI?Mathew R. Williams, MD, FACC

Crossfire

DebAte: cost: : David J. Cohen, MD, FACC : : Huon H. Gray, MD, FACC

DebAte: transapical vs. transfemoral: : Transpical Vinod H. Thourani, MD, FACC

: : Transfemoral Susheel K. Kodali, MD

PreSIDentIAL PerSPectIVe

clinical and Societal Adoption: : ACC Perspective David R. Holmes, Jr., MD, FACC

: : STS Perspective Michael J. Mack, MD, FACC

FUtUre DIrectIOnS

DebAte: Is it time to expand to Intermediate risk clinical trials?: : Pro Raj Makkar, MD, FACC

: : Con Sanjay Kaul, MD, FACC

PARTNER IIMichael J. Mack, MD, FACC

CoreValve Pivotal

PAneL: tHe cHALLenGInG PAtHWAY FOr InnOVAtIOn In AMerIcA

Next TAVI WaveGregory P. Fontana, MD, FACC

The Apex: Beyond TAVIAnson Cheung, MD

Lessons Learned from Carotid Stenting That May Apply to TAVIGary Roubin, MD, PhD, FACC

How About Minimally Invasive Aortic Valve Replacement that Can be Performed in 60 Minutes?Rakesh Mark Suri, MD, DPhil

Crossfire

Structural Heart Disease: Mitral Valve therapies

eDGe-tO-eDGe rePAIr

The FoundationW. Randolph Chitwood, Jr., MD, FACC

Debate: Percutaneous Application: : Evidence Supports Approval Ted Feldman, MD, FACC

: : Evidence is Inadequate Sanjay Kaul, MD, FACC

: : A Surgeon’s Perspective Alfredo Trento, MD

MInIMALLY InVASIVe SUrGIcAL APPrOAcH

Minimally Invasive Surgical Approach is and will Remain the Gold StandardW. Randolph Chitwood, Jr., MD, FACC

Crossfire

FUtUre DIrectIOnS

Transapical Repair of Perivalvular LeakCarlos E. Ruiz, MD, PhD, FACC

Percutaneous Mitral Valve RepairMichael J. Mack, MD, FACC

Percutaneous Mitral Valve ReplacementJoseph E. Bavaria, MD

Mitral Valve Repair Strategies: Challenging Traditional ParadigmsValavanur A. Subramanian, MD, FACC

Hypertension

Blood Pressure Treatment Targets in Limbo: How Low Should We Go?Guiseppe Mancia, MD, PhD

Controversies in the Treatment of Isolated Systolic Hypertension in the ElderlyNorman Kaplan, MD

Device Based Therapies for HypertensionRonald G. Victor, MD, FACC

Crossfire

Preliminary Scientific Program

October 13 & 14, 2011

Available courses/events:

Í Advances in the Treatment of Heart Failure

Wednesday, October 12, 2011

The Island Hotel

690 Newport Center Drive

Newport Beach

1:45 PM Registration

2:00 – 6:00 PM Presentations

6:00 – 7:00 PM Reception

3.5 AMA PRA Category 1 Credit(s)™

course Directors: Dipti Itchhaporia, MD,

FAcc and Pravin M. Shah, MD, MAcc

this program is complimentary.

Please pre-register online at www.hoag.org/

professionals/education or by calling

(800) 514-4624.

All Following Events To Be Held at The Beverly Hills Hotel, Beverly Hills

Í Cardiac Care Associates Educational Session & Networking Reception

Thursday, October 13, 2011

5:00 – 8:30 PM • Polo Private Room

topics

• Primary Prevention of Heart Disease:

Which test to Do?

• Care of the Advanced Heart Failure Patient

• Networking time

Í “Controversies” Celebration & CA ACC Awards Dinner

Friday, October 14, 2011

6:30 – 10:30 PM • Sunset Foyer/Ballroom

cA Acc Members/Guests -

complimentary/$30. controversies

Attendees just $75. Advance reservations

reQUIreD. come enjoy a memorable night

featuring camaraderie, décor, delectable

dinner, and world-class entertainment – a

gift from cA Acc to those that care for our

partners. Featuring entertainment fresh from

Amsterdam: Jennifer Lynn!

Other cA Acc events : (by invitation only)

Í CA ACC and Strategic Partners Luncheon

Friday, October 14, 2011

12:00 – 1:30 PM • Polo Lounge

Hosted by:

cA Acc President George L. Smith, MD, FAcc

Í CA ACC Board of Directors/Council/ Committee Meeting

Saturday, October 15, 2011

7:30 AM - 1:30 PM • Rodeo West Room

Elected/Appointed Leaders

breakfast, Meetings, Lunch. Addressing

all of the hot topics facing cardiology in

california today.

CALIFORNIA CHAPTER OF THE AMERICAN COLLEGE OF CARDIOLOGY MISSION:

To advocate for accessible, highest quality, cost effective cardiovascular care for Californians.

PROuD PARTNER OF THE

22ND Annual Meeting Satellite Events

Providing Ongoing Education of Cardiologists and Team Members

October 13 & 14, 2011

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

October 13 & 14, 2011 • The Beverly Hills Hotel - Beverly Hills, California

Registration Information$495 Physician/Industry through September 23, 2011$595 Physician/Industry after September 23, 2011$395 Resident/Nurse/Technician through

September 23, 2011$495 Resident/Nurse/Technician after

September 23, 2011$395 for ACC Physician Members/

STS Physician Members $195 California Chapter ACC members/

Cardiac Care Associate/STS Associate Members & Candidate Members

Registration fees include breaks, lunches, and welcome reception, as well as scientific program materials. Please make checks payable to Promedica International in U.S. dollars drawn on a U.S. bank. Visa, MasterCard, Discover and American Express credit cards are also accepted. Registrations should be faxed, mailed or submitted online at www.promedicacme.com.

To register, please complete the attached form and mail or fax to:

Promedica International 2333 State Street, Suite 203, Carlsbad, CA 92008 Tel: (760) 720-2263, Fax: (760) 720-6263 Lsteigerwald@promedicacme.com

Refunds

All cancellations must be submitted in writing, via facsimile or postal mail. Refunds are subject to a $100 administration charge. Cancellations cannot be accepted over the telephone. Refunds will not be available after September 23, 2011.

Hotel Accommodations

A special room rate of $395 per night plus tax at the celebrated Beverly Hills Hotel has been arranged for program participants. Reserve your room prior to the cutoff date of September 16, 2011 by calling 1-800-283-8885, or 1-310-276-2251, or email reservations@beverlyhillshotel.com. Mention your affiliation with the Controversies and Advances in the Treatment of Cardiovascular Disease symposium to receive the special rate.

CME Accreditation and Designation

Promedica International is accredited by the Accreditation Council for Continuing Medical Education to

provide continuing medical education for physicians. Promedica International designates this live activity for a maximum of 18 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider #8495 for 18 Contact Hours.

The American Board of Cardiovascular Perfusion (ABCP) has awarded this program a maximum of 21.2 Category 1 CEUs.

Activity Evaluation

Evaluation by online questionnaire will address content, presentation, and future educational needs.

Physician/Industry: $495 through September 23, 2011 $595 after September 23, 2011

Resident/Nurse/Technician: $395 through September 23, 2011 $495 after September 23, 2011

ACC Physician Members/ STS Physician Members: $395

California Chapter ACC Members/Cardiac Care Associates/ STS Associate Members & Candidate Members: $195

“Controversies” Celebration & CA ACC Awards Dinner ACC Members ComplimentaryCA ACC Member Guests $30“Controversies” Attendees $75 No. of Guests___________

P Advances in Heart Failure

P Cardiac Care Session

P “Controversies” Awards Dinner

CA ACC Events Check if you are attending:

Please mail or fax to: Promedica International, 2333 State Street, Suite 203, Carlsbad, CA 92008

Tel: (760) 720-2263, Fax: (760) 720-6263, Lsteigerwald@promedicacme.com

All fees in US dollars drawn on US banks:

P Check Enclosed P Visa/MasterCard

P American Express P Discover

Cr'edit Card Number Expiration Date

Signature

First/Last Name P MD PRN PCCP PNP

Institution

Mailing Address

City/State/Zip/Country

Telephone Fax

Email Address Specialty

Visit us at www.promedicacme.com for convenient online registration.

Pro

med

ica

Inte

rnat

ion

al

2333

Sta

te S

tree

t, Su

ite 2

03

car

lsba

d, c

A 9

200

8P

reso

rt S

tan

dar

d

U.S

. Po

stag

e

Paid

Perm

it 19

48

San

Die

go C

A

WH

AT

TH

EY

’RE

SA

YIN

G:

: : c

onsi

sten

tly g

reat

con

fere

nce

, yea

r aft

er y

ear!

: : A

s al

way

s, th

e “c

ontr

over

sies

” com

mitt

ee p

rese

nte

d

the

late

st a

nd

gre

ates

t in

car

dio

vasc

ula

r res

earc

h a

nd

tr

eatm

ent i

n a

pro

voca

tive

and

inn

ovat

ive

form

at.

: : A

wel

l-des

erve

d re

puta

tion

for a

hig

h-q

ual

ity p

rogr

am!

: : Fo

rmat

was

exc

elle

nt f

or h

eari

ng

con

flic

tin

g vi

ews

of

exp

erts

on

topi

cs re

leva

nt t

o m

y c

linic

al p

ract

ice.

: : t

he

pres

enta

tion

s w

ere

info

rmat

ive

and

en

tert

ain

ing.

O

ne

of th

e be

st m

eeti

ngs

I’ve

att

end

ed!

: : e

xcel

len

t cou

rse,

I le

arn

ed a

lot f

rom

the

deb

ate

form

at.

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

October 13 & 14, 2011 • The Beverly Hills Hotel - Beverly Hills, California

Co

ntr

ov

ers

ies

&

Ad

va

nce

s

IN T

HE

TR

EA

TM

EN

T O

F C

AR

DIO

VA

SC

UL

AR

DIS

EA

SE

Th

e E

lev

en

th in

th

e S

eri

es

• O

cto

be

r 13

& 1

4, 2

011

Th

e B

ev

erl

y H

ills

Ho

tel

– B

ev

erl

y H

ills

, Ca

lifo

rnia

22ST

An

nu

al M

eeti

ng

of th

e C

alif

orn

ia A

CC